Lee CH - Search Results

1

Clinical characteristics and prognostic importance of mild-to-moderate noninfarct-related coronary artery disease in patients with first ST-elevation myocardial infarction.

Soo WM, Chan MY, Beck L, Lim SL, Lee CH, Poh KK. Soo WM, et al. Among authors: lee ch. Coron Artery Dis. 2011 Mar;22(1):55-8. doi: 10.1097/mca.0b013e32834236b9. Coron Artery Dis. 2011. PMID: 21400741

2

Predictors of survival after contemporary percutaneous coronary revascularization for acute myocardial infarction in the real world.

Lee CH, van Domburg RT, Hoye A, Lemos PA, Tanabe K, Smits PC, van der Giessen WJ, de Feyter P, Serruys PW. Lee CH, et al. J Invasive Cardiol. 2004 Nov;16(11):627-31. J Invasive Cardiol. 2004. PMID: 15550731

3

Direct stenting compared to conventional stenting in Diabetic Patients Undergoing Elective Angioplasty for Coronary Artery Disease (DECIDE): a multicenter, open label, randomized, controlled efficacy study.

Tan HC, Lim YT, Rosli TL, Sim KH, Tan KH, Lee CH, Ismail O, Azman W. Tan HC, et al. Among authors: lee ch. Am Heart J. 2004 Dec;148(6):1007-11. doi: 10.1016/j.ahj.2004.07.002. Am Heart J. 2004. PMID: 15632886 Clinical Trial.

4

Impact of glycemic control on occurrence of no-reflow and 30-day outcomes in diabetic patients undergoing primary angioplasty for myocardial infarction.

Lee CH, Teo SG, Hong E, Wong HB, Low A, Sutandar A, Tan HC, Lim YT. Lee CH, et al. J Invasive Cardiol. 2005 Aug;17(8):422-6. J Invasive Cardiol. 2005. PMID: 16079448

5

Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.

Lee CH, Wong HB, Tan HC, Zhang JJ, Teo SG, Ong HY, Low A, Sutandar A, Lim YT. Lee CH, et al. J Interv Cardiol. 2005 Aug;18(4):261-6. doi: 10.1111/j.1540-8183.2005.00041.x. J Interv Cardiol. 2005. PMID: 16115155 Free article.

6

Fluvastatin: efficacy and safety in reducing cardiac events.

Chan MY, Lee CH. Chan MY, et al. Among authors: lee ch. Expert Opin Pharmacother. 2005 Sep;6(11):1883-95. doi: 10.1517/14656566.6.11.1883. Expert Opin Pharmacother. 2005. PMID: 16144508 Review.

7

Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus.

Lee CH, Chan MY. Lee CH, et al. Int J Cardiol. 2007 Jan 18;114(3):e107-8. doi: 10.1016/j.ijcard.2006.07.197. Epub 2006 Nov 3. Int J Cardiol. 2007. PMID: 17084471 No abstract available.

8

Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study.

Lee CH, Low A, Tai BC, Co M, Chan MY, Lim J, Lim YT, Tan HC. Lee CH, et al. Eur Heart J. 2007 Jan;28(1):19-25. doi: 10.1093/eurheartj/ehl411. Epub 2006 Nov 28. Eur Heart J. 2007. PMID: 17132650 Clinical Trial.

9

Sirolimus-eluting, bioabsorbable polymer-coated constant stent (Cura) in acute ST-elevation myocardial infarction: a clinical and angiographic study (CURAMI Registry).

Lee CH, Lim J, Low A, Zhang XL, Kyaing TT, Chan MY, Wong HB, Lim YT, Tan HC. Lee CH, et al. J Invasive Cardiol. 2007 Apr;19(4):182-5. J Invasive Cardiol. 2007. PMID: 17404404

10

Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate- to long-term clinical follow-up.

Co M, Tay E, Lee CH, Poh KK, Low A, Lim J, Lim IH, Lim YT, Tan HC. Co M, et al. Among authors: lee ch. Am Heart J. 2008 Jan;155(1):128-32. doi: 10.1016/j.ahj.2007.08.031. Epub 2007 Nov 26. Am Heart J. 2008. PMID: 18082503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,929 results

Search Page

Filters